NCT07417904 BRAVE Program to Improve Safety and Reduce Violence Risk in Early Psychosis
| NCT ID | NCT07417904 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Howard University |
| Condition | Violence Risk |
| Study Type | INTERVENTIONAL |
| Enrollment | 30 participants |
| Start Date | 2026-07-02 |
| Primary Completion | 2027-08 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 30 participants in total. It began in 2026-07-02 with a primary completion date of 2027-08.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
This study evaluates the feasibility and acceptability of BRAVE, a manualized cognitive behavioral therapy (CBT)-based intervention designed to address dynamic risk factors for violence among young adults with early psychosis. Using a stepped-wedge randomized design, all participants will receive treatment as usual followed by the BRAVE intervention. The study will also explore changes in violence-related behaviors and treatment engagement over time.
Eligibility Criteria
Inclusion Criteria: * Young adults aged 16-30 years * Diagnosis of early psychosis * Currently receiving outpatient care through an early psychosis clinic * Psychiatrically stable and deemed appropriate for participation by a treating clinician * Able and willing to provide informed consent Exclusion Criteria: * Unable to provide informed consent * Not fluent in English * History of antisocial behavior, as assessed at baseline * Immediate risk requiring a higher level of care
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07417904 clinical trial?
This trial is open to participants of all sexes, aged 16 Years or older, up to 30 Years, studying Violence Risk. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07417904 currently recruiting?
Yes, NCT07417904 is actively recruiting participants. Contact the research team at stephanie.rolin@howard.edu for enrollment information.
Where is the NCT07417904 trial being conducted?
This trial is being conducted at Washington D.C., United States, Washington D.C., United States.
Who is sponsoring the NCT07417904 clinical trial?
NCT07417904 is sponsored by Howard University. The trial plans to enroll 30 participants.